Posts Tagged ‘Novocure’

Bill Doyle

Bill Doyle is the executive chairman of Novocure, an oncology company developing a novel cancer treatment using a proprietary therapy called TTFields, which uses electric fields to disrupt solid tumor cancer cell division. He is also executive chairman of Blink Health, a digital savings platform tackling the high cost of prescription medications. Previously, Bill servedRead more..